Robin Wilson

989 total citations
23 papers, 691 citations indexed

About

Robin Wilson is a scholar working on Pharmacology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Robin Wilson has authored 23 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 11 papers in Psychiatry and Mental health and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Robin Wilson's work include Cannabis and Cannabinoid Research (17 papers), Schizophrenia research and treatment (8 papers) and Neuroscience and Neuropharmacology Research (6 papers). Robin Wilson is often cited by papers focused on Cannabis and Cannabinoid Research (17 papers), Schizophrenia research and treatment (8 papers) and Neuroscience and Neuropharmacology Research (6 papers). Robin Wilson collaborates with scholars based in United Kingdom, Netherlands and Spain. Robin Wilson's co-authors include Sagnik Bhattacharyya, Matthijs G. Bossong, Paul Allen, Philip McGuire, Aisling O’Neill, Marco Colizzi, Elizabeth Appiah‐Kusi, Grace Blest‐Hopley, Matthew J. Kempton and Jesús Pérez and has published in prestigious journals such as The Lancet, Psychological Medicine and Schizophrenia Bulletin.

In The Last Decade

Robin Wilson

23 papers receiving 679 citations

Peers

Robin Wilson
Ashley M. Schnakenberg Martin United States
Meghan M. Grady United States
Stephanie Collins Reed United States
Jose Cortes-Briones United States
Brooke Short Australia
Susan Quello United States
Hollis C. Karoly United States
J.A.S. Crippa Brazil
Saulo C. M. Ribeiro United States
Boukje A.G. Dijkstra Netherlands
Ashley M. Schnakenberg Martin United States
Robin Wilson
Citations per year, relative to Robin Wilson Robin Wilson (= 1×) peers Ashley M. Schnakenberg Martin

Countries citing papers authored by Robin Wilson

Since Specialization
Citations

This map shows the geographic impact of Robin Wilson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Wilson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Wilson more than expected).

Fields of papers citing papers by Robin Wilson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Wilson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Wilson. The network helps show where Robin Wilson may publish in the future.

Co-authorship network of co-authors of Robin Wilson

This figure shows the co-authorship network connecting the top 25 collaborators of Robin Wilson. A scholar is included among the top collaborators of Robin Wilson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Wilson. Robin Wilson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davies, Cathy, Matthijs G. Bossong, Daniel Martins, et al.. (2023). Increased hippocampal blood flow in people at clinical high risk for psychosis and effects of cannabidiol. Psychological Medicine. 54(5). 993–1003. 4 indexed citations
2.
Davies, Cathy, Matthijs G. Bossong, Daniel Martins, et al.. (2023). Hippocampal Glutamate, Resting Perfusion and the Effects of Cannabidiol in Psychosis Risk. Schizophrenia Bulletin Open. 4(1). sgad022–sgad022. 2 indexed citations
3.
Wilson, Robin, et al.. (2022). Cannabidiol attenuates insular activity during motivational salience processing in patients with early psychosis. Psychological Medicine. 53(10). 4732–4741. 7 indexed citations
4.
Davies, Cathy, Elizabeth Appiah‐Kusi, Robin Wilson, et al.. (2021). Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary report. European Archives of Psychiatry and Clinical Neuroscience. 272(3). 461–475. 14 indexed citations
5.
O’Neill, Aisling, et al.. (2021). Cannabidiol modulation of hippocampal glutamate in early psychosis. Journal of Psychopharmacology. 35(7). 814–822. 22 indexed citations
6.
O’Neill, Aisling, Robin Wilson, Grace Blest‐Hopley, et al.. (2020). Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis. Psychological Medicine. 51(4). 596–606. 51 indexed citations
7.
Davies, Cathy, Robin Wilson, Elizabeth Appiah‐Kusi, et al.. (2020). A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis. Translational Psychiatry. 10(1). 311–311. 27 indexed citations
8.
Wilson, Robin, Matthijs G. Bossong, Elizabeth Appiah‐Kusi, et al.. (2019). Cannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis. Translational Psychiatry. 9(1). 203–203. 44 indexed citations
9.
Blest‐Hopley, Grace, Aisling O’Neill, Robin Wilson, Vincent Giampietro, & Sagnik Bhattacharyya. (2019). Disrupted parahippocampal and midbrain function underlie slower verbal learning in adolescent-onset regular cannabis use. Psychopharmacology. 238(5). 1315–1331. 15 indexed citations
10.
Wilson, Robin, Marco Colizzi, Matthijs G. Bossong, et al.. (2018). Correction to: The Neural Substrate of Reward Anticipation in Health: A Meta-Analysis of fMRI Findings in the Monetary Incentive Delay Task. Neuropsychology Review. 28(4). 507–508. 3 indexed citations
11.
Wilson, Robin, Marco Colizzi, Matthijs G. Bossong, et al.. (2018). The Neural Substrate of Reward Anticipation in Health: A Meta-Analysis of fMRI Findings in the Monetary Incentive Delay Task. Neuropsychology Review. 28(4). 496–506. 134 indexed citations
12.
Blest‐Hopley, Grace, Aisling O’Neill, Robin Wilson, Vincent Giampietro, & Sagnik Bhattacharyya. (2018). T99. LONG-TERM CANNABIS USE ASSOCIATED WITH ALTERED FUNCTIONING DURING VERBAL LEARNING. Schizophrenia Bulletin. 44(suppl_1). S154–S154. 1 indexed citations
13.
Bhattacharyya, Sagnik, Robin Wilson, Paul Allen, et al.. (2018). 17.3 EFFECT OF CANNABIDIOL ON SYMPTOMS, DISTRESS AND NEUROPHYSIOLOGICAL ABNORMALITIES IN CLINICAL HIGH-RISK FOR PSYCHOSIS PATIENTS: A PLACEBO-CONTROLLED STUDY. Schizophrenia Bulletin. 44(suppl_1). S28–S28. 7 indexed citations
14.
O’Neill, Aisling, et al.. (2018). S152. CANNABIDIOL INDUCED MODULATION OF MEDIOTEMPORAL ACTIVITY DURING A VERBAL MEMORY TASK IN FIRST-EPISODE PSYCHOSIS. Schizophrenia Bulletin. 44(suppl_1). S384–S384. 3 indexed citations
15.
Bhattacharyya, Sagnik, Robin Wilson, Elizabeth Appiah‐Kusi, et al.. (2018). Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis. JAMA Psychiatry. 75(11). 1107–1107. 106 indexed citations
16.
O’Neill, Aisling, Robin Wilson, Elizabeth Appiah‐Kusi, et al.. (2017). SU71. Effects of Cannabidiol on Mediotemporal and Dorsostriatal Activity During Encoding and Recall, in the At-Risk Mental State for Psychosis. Schizophrenia Bulletin. 43(suppl_1). S187–S187. 2 indexed citations
17.
Patel, Rashmi, Robin Wilson, Richard Jackson, et al.. (2016). Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study. BMJ Open. 6(3). e009888–e009888. 106 indexed citations
18.
Patel, Rashmi, Robin Wilson, Richard Jackson, et al.. (2015). Cannabis use and treatment resistance in first episode psychosis: a natural language processing study. The Lancet. 385. S79–S79. 26 indexed citations
19.
Bell, James, et al.. (2013). Use of electronic health records in identifying drug and alcohol misuse among psychiatric in-patients. The Psychiatrist. 37(1). 15–20. 9 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ashley M. Schnakenberg Martin Breakdown of academic impact, for papers by Meghan M. Grady Breakdown of academic impact, for papers by Stephanie Collins Reed Breakdown of academic impact, for papers by Jose Cortes-Briones Breakdown of academic impact, for papers by Brooke Short Breakdown of academic impact, for papers by Susan Quello Breakdown of academic impact, for papers by Hollis C. Karoly Breakdown of academic impact, for papers by J.A.S. Crippa Breakdown of academic impact, for papers by Saulo C. M. Ribeiro Breakdown of academic impact, for papers by Boukje A.G. Dijkstra
Rankless by CCL
2026